Constant Therapy Health is a digital therapeutics company providing evidence-based speech and cognitive therapy for stroke, traumatic brain injury (TBI), Parkinson's disease, and other neurological conditions. The company's platform uses clinically-validated exercises to help patients recover speech, language, and cognitive function through personalized, adaptive therapy programs.
The company was founded with the mission of making high-quality speech and cognitive therapy accessible to patients recovering from neurological conditions, particularly those who face barriers to in-person therapy such as transportation challenges, geographic limitations, or financial constraints.
Constant Therapy's platform uses adaptive algorithms to personalize therapy based on individual patient performance:
- Initial assessment: Comprehensive evaluation of speech, language, and cognitive abilities
- Adaptive difficulty: Exercises automatically adjust based on patient performance
- Progress tracking: Continuous monitoring of patient progress over time
- Customizable programs: Therapy can be tailored to specific conditions and goals
The platform is built on clinically-validated research:
- Exercises based on established speech-language pathology techniques
- Integration of LSVT (Lee Silverman Voice Treatment) principles for Parkinson's disease
- Cognitive therapy exercises validated in clinical trials
- Regular updates based on ongoing clinical research
Constant Therapy provides multiple accessibility features:
- Telepractice capabilities: Enables remote therapy sessions
- Multiple platforms: Available on web, iOS, and Android devices
- Clinician dashboard: Allows speech-language pathologists to monitor and adjust therapy
- Caregiver tools: Supports family members in assisting with therapy
Digital therapy has shown efficacy in stroke rehabilitation:
- Aphasia treatment: Exercises targeting word retrieval, sentence construction, and comprehension
- Dysarthria therapy: Speech clarity and articulation exercises
- Cognitive rehabilitation: Memory, attention, and executive function training
For patients with Parkinson's disease, Constant Therapy incorporates speech therapy exercises:
- LSVT LOUD principles: Amplitude-based vocal exercises
- Respiratory training: Supporting speech power and clarity
- Articulation exercises: Improving speech intelligibility
The platform addresses cognitive and language deficits common after TBI:
- Attention training: Sustained, selective, and divided attention exercises
- Memory exercises: Working memory and long-term memory training
- Executive function: Problem-solving and reasoning exercises
¶ Research and Evidence
Multiple studies have evaluated digital therapy effectiveness:
- Stroke rehabilitation outcomes showing improvement in language function
- Cost-effectiveness analysis demonstrating value of digital approaches
- Technology-enabled therapy showing comparable outcomes to in-person therapy
The platform incorporates machine learning approaches:
- Adaptive difficulty algorithms
- Personalized exercise selection
- Predictive analytics for progress monitoring
Constant Therapy operates in the digital therapeutics space competing with:
- Traditional speech-language pathology services
- Other digital therapy platforms (e.g., Lingual)
- Home-based therapy programs
The company differentiates through:
- Evidence-based exercise library
- Clinician integration features
- Multiple condition coverage
- FDA cleared medical device
- Insurance reimbursement available through some providers
- HIPAA compliant for patient data security
The adaptive learning engine underlying Constant Therapy represents a sophisticated integration of machine learning and cognitive science principles. The system employs several key algorithmic approaches:
Constant Therapy utilizes item response theory (IRT) to optimize question difficulty and patient progression:
The platform implements evidence-based spaced repetition for optimal learning:
- Leitner system: Progressive box system for review scheduling
- SuperMemo algorithm: Interval optimization based on retention
- Forgetting curve modeling: Personalized review timing
- Memory consolidation: Leveraging sleep-dependent consolidation
Beyond rule-based systems, Constant Therapy employs machine learning for personalization:
- Performance pattern recognition: Identifying individual strengths/weaknesses
- Learning rate modeling: Adapting to individual acquisition speeds
- Error prediction: Preemptively addressing likely errors
- Outcome prediction: Forecasting recovery trajectories
¶ Data Analytics and Insights
The platform generates significant data for clinical insights:
- Progress tracking: Detailed metrics on improvement over time
- Benchmarking: Comparison to normative data and similar patients
- Adherence monitoring: Tracking usage patterns and engagement
- Outcome prediction: Estimating final recovery levels
- Caseload overview: Summary of all patient progress
- Alerts and notifications: Flagging patients needing attention
- Outcome reporting: Aggregated outcomes across practice
- Resource allocation: Time estimates for treatment planning
Constant Therapy provides robust integration capabilities:
- HL7 FHIR support: Modern healthcare data standards
- CCD documents: Continuity of Care Document compatibility
- ADT messages: Admission, Discharge, Transfer integration
- Order entry: Therapy prescription integration
- Practice management systems: Scheduling and billing integration
- Telehealth platforms: Video session integration
- Device connectivity: Wearable and sensor integration
- Research databases: De-identified data export for research
Constant Therapy operates in the growing digital therapeutics market:
| Market Segment |
2024 Value |
2030 Projected |
CAGR |
| Digital therapeutics overall |
$8.5 billion |
$25 billion |
20% |
| Neurological DTX |
$1.2 billion |
$4.5 billion |
25% |
| Speech therapy DTX |
$300 million |
$1.2 billion |
26% |
| Cognitive DTX |
$500 million |
$2 billion |
26% |
The digital therapeutics market includes several competing approaches:
| Company |
Platform |
Strengths |
Limitations |
| Constant Therapy |
Adaptive learning |
Evidence base, broad覆盖 |
Platform-specific |
| Tali |
Pediatric focus |
Gamification, engagement |
Limited adult use |
| BrainHQ |
Cognitive training |
Extensive research |
Not condition-specific |
| Cogmed |
Working memory |
Structured protocol |
Narrow focus |
¶ Reimbursement Landscape
Reimbursement for digital therapeutics continues to evolve:
- Medicare: Limited coverage as DME in some cases
- Medicaid: State-dependent coverage
- Commercial: Growing coverage, particularly in ASO plans
- Veterans: VA coverage available
Constant Therapy engages in coverage advocacy:
- Clinical evidence development: Generating health economic data
- Policy engagement: Working with payers on coverage criteria
- Provider education: Training clinicians on documentation
- Patient advocacy: Supporting patient access initiatives
Constant Therapy operates on multiple revenue models:
- Individual subscription: Direct patient access
- Clinician subscription: Professional license for clinicians
- Institutional license: Hospital/health system access
- Health system contracts: Enterprise-wide deployment
- Payer partnerships: Value-based care arrangements
- Research partnerships: Academic and industry research
¶ Data and Insights
- De-identified data: Aggregated insights for research
- Outcomes analytics: Benchmarking and reporting services
- Quality measurement: Outcomes-based reporting
Pricing varies by segment:
| Segment |
Pricing Model |
Price Range |
| Individual patient |
Monthly subscription |
$30-50/month |
| Clinician |
Annual license |
$500-2,000/year |
| Health system |
Per-member-per-month |
$2-10 PMPM |
| Research |
Data access |
Custom pricing |
Constant Therapy has been validated in multiple peer-reviewed publications:
¶ Stroke and Aphasia
Constantb et al. demonstrated significant improvements in naming accuracy and language function among post-stroke patients using the platform compared to standard care alone. Key findings included:
- 40% greater improvement in naming accuracy
- 85% therapy adherence rate
- Significantly lower cost per functional improvement
Studies have examined digital delivery of voice therapy for PD:
- Parkinsons et al. showed improvements in vocal acoustic measures
- Cacciatore et al. demonstrated feasibility of remote therapy approaches
- Improvements in patient-reported outcomes
Research on TBI cognitive rehabilitation:
- Godlove et al. found evidence for attention and memory improvement
- Chen et al. demonstrated comparable outcomes to traditional therapy
- Enhanced accessibility and cost-effectiveness
Constant Therapy continues to generate evidence:
- Multiple clinical trials: Active studies in stroke, PD, TBI
- Health economic studies: Cost-effectiveness analyses
- Real-world evidence: Registry and outcomes studies
- Comparative effectiveness: Head-to-head studies with standard care
Constant Therapy navigates the evolving digital therapeutics regulatory landscape:
- FDA cleared: Multiple clinical claims
- 510(k) pathway: For software as medical device
- Class II device: Moderate risk classification
- Indication for use: Specified neurological conditions
- Claims support: Clinical efficacy claims
- Intended users: Clinicians and patients
The company maintains robust quality systems:
- ISO 13485: Medical device quality management
- HIPAA compliance: Data protection requirements
- SOC 2: Security and availability
- GDPR compliance: International data protection
Planned platform enhancements include:
- AI-powered features: More sophisticated personalization
- Expanded modalities: Additional therapy types
- Wearable integration: Direct sensor connectivity
- Language expansion: Multilingual therapy delivery
Constant Therapy's long-term strategy includes:
- Platform expansion: Broadening beyond speech/cognitive therapy
- Global reach: International market expansion
- Disease expansion: Additional neurological conditions
- Integration depth: Deeper healthcare system integration
Key strategic initiatives driving future growth:
- Evidence generation: Continued clinical validation
- Payer partnerships: Expanding coverage and reimbursement
- Technology innovation: AI and machine learning advancement
- Market expansion: International and segment growth
The adaptive learning engine underlying Constant Therapy represents a sophisticated integration of machine learning and cognitive science principles. The system employs several key algorithmic approaches:
Constant Therapy utilizes item response theory (IRT) to optimize question difficulty and patient progression:
- Difficulty parameters: Each exercise item has calibrated difficulty levels
- Patient ability estimation: Continuous estimation of patient capability
- Information function: Maximizing information gain per response
- Computerized adaptive testing: Real-time difficulty adjustment
The platform implements evidence-based spaced repetition for optimal learning:
- Leitner system: Progressive box system for review scheduling
- SuperMemo algorithm: Interval optimization based on retention
- Forgetting curve modeling: Personalized review timing
- Memory consolidation: Leveraging sleep-dependent consolidation
Beyond rule-based systems, Constant Therapy employs machine learning for personalization:
- Performance pattern recognition: Identifying individual strengths/weaknesses
- Learning rate modeling: Adapting to individual acquisition speeds
- Error prediction: Preemptively addressing likely errors
- Outcome prediction: Forecasting recovery trajectories
¶ Data Analytics and Insights
The platform generates significant data for clinical insights:
- Progress tracking: Detailed metrics on improvement over time
- Benchmarking: Comparison to normative data and similar patients
- Adherence monitoring: Tracking usage patterns and engagement
- Outcome prediction: Estimating final recovery levels
- Caseload overview: Summary of all patient progress
- Alerts and notifications: Flagging patients needing attention
- Outcome reporting: Aggregated outcomes across practice
- Resource allocation: Time estimates for treatment planning
Constant Therapy provides robust integration capabilities:
- HL7 FHIR support: Modern healthcare data standards
- CCD documents: Continuity of Care Document compatibility
- ADT messages: Admission, Discharge, Transfer integration
- Order entry: Therapy prescription integration
- Practice management systems: Scheduling and billing integration
- Telehealth platforms: Video session integration
- Device connectivity: Wearable and sensor integration
- Research databases: De-identified data export for research
Constant Therapy operates in the growing digital therapeutics market:
| Market Segment |
2024 Value |
2030 Projected |
CAGR |
| Digital therapeutics overall |
$8.5 billion |
$25 billion |
20% |
| Neurological DTX |
$1.2 billion |
$4.5 billion |
25% |
| Speech therapy DTX |
$300 million |
$1.2 billion |
26% |
| Cognitive DTX |
$500 million |
$2 billion |
26% |
The digital therapeutics market includes several competing approaches:
| Company |
Platform |
Strengths |
Limitations |
| Constant Therapy |
Adaptive learning |
Evidence base, broad覆盖 |
Platform-specific |
| Tali |
Pediatric focus |
Gamification, engagement |
Limited adult use |
| BrainHQ |
Cognitive training |
Extensive research |
Not condition-specific |
| Cogmed |
Working memory |
Structured protocol |
Narrow focus |
¶ Reimbursement Landscape
Reimbursement for digital therapeutics continues to evolve:
- Medicare: Limited coverage as DME in some cases
- Medicaid: State-dependent coverage
- Commercial: Growing coverage, particularly in ASO plans
- Veterans: VA coverage available
Constant Therapy engages in coverage advocacy:
- Clinical evidence development: Generating health economic data
- Policy engagement: Working with payers on coverage criteria
- Provider education: Training clinicians on documentation
- Patient advocacy: Supporting patient access initiatives
Constant Therapy operates on multiple revenue models:
- Individual subscription: Direct patient access
- Clinician subscription: Professional license for clinicians
- Institutional license: Hospital/health system access
- Health system contracts: Enterprise-wide deployment
- Payer partnerships: Value-based care arrangements
- Research partnerships: Academic and industry research
¶ Data and Insights
- De-identified data: Aggregated insights for research
- Outcomes analytics: Benchmarking and reporting services
- Quality measurement: Outcomes-based reporting
Pricing varies by segment:
| Segment |
Pricing Model |
Price Range |
| Individual patient |
Monthly subscription |
$30-50/month |
| Clinician |
Annual license |
$500-2,000/year |
| Health system |
Per-member-per-month |
$2-10 PMPM |
| Research |
Data access |
Custom pricing |
Constant Therapy has been validated in multiple peer-reviewed publications:
¶ Stroke and Aphasia
Constantb et al. demonstrated significant improvements in naming accuracy and language function among post-stroke patients using the platform compared to standard care alone. Key findings included:
- 40% greater improvement in naming accuracy
- 85% therapy adherence rate
- Significantly lower cost per functional improvement
Studies have examined digital delivery of voice therapy for PD:
- Parkinsons et al. showed improvements in vocal acoustic measures
- Cacciatore et al. demonstrated feasibility of remote therapy approaches
- Improvements in patient-reported outcomes
Research on TBI cognitive rehabilitation:
- Godlove et al. found evidence for attention and memory improvement
- Chen et al. demonstrated comparable outcomes to traditional therapy
- Enhanced accessibility and cost-effectiveness
Constant Therapy continues to generate evidence:
- Multiple clinical trials: Active studies in stroke, PD, TBI
- Health economic studies: Cost-effectiveness analyses
- Real-world evidence: Registry and outcomes studies
- Comparative effectiveness: Head-to-head studies with standard care
Constant Therapy navigates the evolving digital therapeutics regulatory landscape:
- FDA cleared: Multiple clinical claims
- 510(k) pathway: For software as medical device
- Class II device: Moderate risk classification
- Indication for use: Specified neurological conditions
- Claims support: Clinical efficacy claims
- Intended users: Clinicians and patients
The company maintains robust quality systems:
- ISO 13485: Medical device quality management
- HIPAA compliance: Data protection requirements
- SOC 2: Security and availability
- GDPR compliance: International data protection
Planned platform enhancements include:
- AI-powered features: More sophisticated personalization
- Expanded modalities: Additional therapy types
- Wearable integration: Direct sensor connectivity
- Language expansion: Multilingual therapy delivery
Constant Therapy's long-term strategy includes:
- Platform expansion: Broadening beyond speech/cognitive therapy
- Global reach: International market expansion
- Disease expansion: Additional neurological conditions
- Integration depth: Deeper healthcare system integration
Key strategic initiatives driving future growth:
- Evidence generation: Continued clinical validation
- Payer partnerships: Expanding coverage and reimbursement
- Technology innovation: AI and machine learning advancement
- Market expansion: International and segment growth